Speakers

Colin Hayward

Chief Medical Officer

Telix Pharmaceuticals

David Mankoff

Matthew J. Wilson Professor and Vice-Chair for Research,

University of Pennsylvania

Erik Mittra

Director of Targeted Radionuclide Therapy

OHSU - Oregon Health & Science University

Ian Wilson

Chief Executive Officer

Imaginab

Jason Hurt

Chief Medical Officer

OranoMed

Julia Brosch-Lenz

Medical Physicist

Inserm Lille Neuroscience & Cognition research centre

Luke Nordquist

Chief Executive Officer

Urology Cancer Center & GU Research

Manuel Bardies

Research Director

Inserm

Marc Hedrick

Chief Executive Officer

Plus Therapeutics Inc.

Melissa Moore

Vice President of Clinical Research

PLUS Therapeutics

Michael Shultz

Co-founder & Chief Scientific Officer,

ViewPoint Therapeutics

Mike Sirosky

Product Manager

MIM Software

Mohit Rawat

President and Chief Business Officer

Fusion Pharmaceuticals

Munir Ghesani

Chief of Nuclear Medicine

Icahn School of Medicine at Mount Sinai

Neil Quigley

ITM Global Product Manager

ITM

Norman La France

Chief Medical Officer & Senior Vice President

PLUS Therapeutics

Paddy Gilligan

President

European Federation of Organisations for Medical Physics

Patrick Donahue

Chief Executive Officer

Iotron Medical Inc.

Riccardo Canevari

Chief Executive Officer

Radiopharm Theranostics

Sandesh Seth

Chief Executive Officer

Actinium Pharmaceuticals

Shaemus Gleason

Executive Vice President

Clarity Pharmaceuticals

Sherly Mosessian

Chief Scientific Officer

SOFIE

Shiva Kazerounian

Director of Cancer Biology

, Ratio Therapeutics

Sujiet Puthenveetil

Director

AstraZeneca

Susan Moran

Chief Medical Officer

RayzeBio

2023 EVENT GUIDE
REGISTER
PARTNER WITH US